Ildong Pharmaceutical Co., Ltd. (249420.KS)
KRW 11350.0
(-5.42%)
KRW 11350.0
(-5.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -36.61 Billion | -53.54 Billion | -11.36 Billion | 19.36 Billion | 41.36 Billion | 66.64 Billion |
| Net Income | -78.92 Billion | -142.16 Billion | -100.96 Billion | -13.01 Billion | -13.44 Billion | 12.72 Billion |
| Depreciation & Amortization | 28.31 Billion | 29.54 Billion | 29.31 Billion | 27.66 Billion | 27.91 Billion | 23.59 Billion |
| Deferred income taxes | -39.05 Billion | - | 51.39 Billion | 23.4 Billion | - | - |
| Stock-based compensation | -5.72 Million | 18.08 Million | 16.54 Million | 30.92 Million | - | - |
| Change in working capital | -11.48 Billion | -14.41 Billion | -1.54 Billion | -22.9 Billion | -6.89 Billion | 11.83 Billion |
| Other non-cash items | 64.53 Billion | 73.48 Billion | 10.41 Billion | 4.2 Billion | 33.78 Billion | 18.49 Billion |
| Investing Cash Flow | -20.43 Billion | -26.43 Billion | -43.36 Billion | -18.4 Billion | -14.02 Billion | -22.59 Billion |
| Investments in PPE | -18.18 Billion | -19.6 Billion | -19.79 Billion | -19.2 Billion | -19.35 Billion | -20.79 Billion |
| Acquisitions | 286.6 Million | 367.5 Million | 1.14 Billion | 60 Million | -5.22 Billion | 5.7 Billion |
| Investment purchases | -46 Billion | -74.73 Billion | -28.21 Billion | -2.23 Billion | -8.23 Billion | -2.7 Billion |
| Sales/Maturities of investments | 44.4 Billion | 67.33 Billion | 5.03 Billion | -60 Million | 10.56 Billion | 959.72 Million |
| Other Investing Activities | -927.83 Million | 203.56 Million | -1.53 Billion | 3.04 Billion | 8.22 Billion | -5.76 Billion |
| Financing Cash Flow | 58.22 Billion | -3.28 Billion | 104.31 Billion | -4.57 Billion | -13.48 Billion | -7.91 Billion |
| Debt repayment | -64.05 Billion | -40 Billion | -141.6 Billion | -240.6 Billion | -183.6 Billion | -159.61 Billion |
| Dividends payments | -160 Million | -120 Million | - | - | -8.63 Billion | -7.84 Billion |
| Common Stock Repurchased | -1.94 Billion | - | - | -43.33 Million | -72.9 Million | -62.78 Million |
| Common Stock Issuance | 124.83 Million | - | 1.74 Billion | - | - | - |
| Other Financing Activities | 124.24 Billion | 36.83 Billion | 244.17 Billion | 236.06 Billion | 178.82 Billion | 159.61 Billion |
| Accounts receivables | -506.18 Million | -1.95 Billion | -3.41 Billion | 16.08 Billion | 8.93 Billion | 24.69 Billion |
| Accounts payables | 4.23 Billion | 7.93 Billion | 2.33 Billion | -3.72 Billion | 19.22 Billion | -6.18 Billion |
| Inventory | 13.85 Billion | -15.53 Billion | 6.61 Billion | -19.03 Billion | -28.53 Billion | 7.22 Billion |
| Other working capital | -29.06 Billion | -4.86 Billion | -7.08 Billion | -16.23 Billion | -6.51 Billion | 4.61 Billion |
| Cash at beginning of period | 52.14 Billion | 135.58 Billion | 85.56 Billion | 89.95 Billion | 75.93 Billion | 39.94 Billion |
| Cash at end of period | 53.25 Billion | 52.14 Billion | 135.58 Billion | 85.56 Billion | 89.95 Billion | 75.93 Billion |
| Capital Expenditure | -18.18 Billion | -19.6 Billion | -19.79 Billion | -19.2 Billion | -19.35 Billion | -20.79 Billion |
| Effect of forex changes on cash | -64.18 Million | -177.19 Million | 440.43 Million | -782.08 Million | 166.27 Million | -144.51 Million |
| Net cash flow / Change in cash | 1.11 Billion | -83.44 Billion | 50.02 Billion | -4.39 Billion | 14.02 Billion | 35.99 Billion |
| Free Cash Flow | -54.8 Billion | -73.14 Billion | -31.15 Billion | 160.22 Million | 22.01 Billion | 45.85 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.23 Billion | -833.32 Million | 1.41 Billion | -78.92 Billion | -46.49 Billion | -24.43 Billion |
| Depreciation & Amortization | 6.44 Billion | 6.27 Billion | 6.68 Billion | 28.31 Billion | 6.79 Billion | 7.32 Billion |
| Deferred income taxes | - | - | 9.3 Billion | -39.05 Billion | - | 4.38 Billion |
| Stock-based compensation | - | - | -11.13 Million | -5.72 Million | - | 1.35 Million |
| Change in working capital | -3.51 Billion | -10.13 Billion | 15.3 Billion | -11.48 Billion | -13.4 Billion | -4.39 Billion |
| Other non-cash items | 7.29 Billion | 15.13 Billion | -15.3 Billion | 64.53 Billion | 26.64 Billion | 2.93 Billion |
| Investing Cash Flow | -5.73 Billion | -426.26 Million | -1.84 Billion | -20.43 Billion | -21.94 Billion | -4.65 Billion |
| Investments in PPE | -2.56 Billion | -3.28 Billion | -2.88 Billion | -18.18 Billion | -6.81 Billion | -4.62 Billion |
| Acquisitions | - | - | 11.5 Million | 286.6 Million | 1.3 Billion | -1.4 Billion |
| Investment purchases | -80.5 Million | -179.98 Million | -10.06 Billion | -46 Billion | -20.99 Billion | -845 Million |
| Sales/Maturities of investments | 3 Billion | 3 Billion | 13 Billion | 44.4 Billion | 2.8 Billion | 600 Million |
| Other Investing Activities | -3.17 Billion | 37.91 Million | -1.9 Billion | -927.83 Million | 1.75 Billion | 1.62 Billion |
| Financing Cash Flow | -1.14 Billion | -1.05 Billion | 5.2 Billion | 58.22 Billion | 42.4 Billion | 11.72 Billion |
| Debt repayment | -619.71 Million | -400 Million | -21.4 Billion | -64.05 Billion | -13.4 Billion | -2 Billion |
| Dividends payments | -76.8 Million | - | - | -160 Million | - | -160 Million |
| Common Stock Repurchased | - | - | -1.94 Billion | -1.94 Billion | - | - |
| Common Stock Issuance | - | - | 124.83 Million | 124.83 Million | - | - |
| Other Financing Activities | -450 Million | -29.39 Billion | 28.42 Billion | 124.24 Billion | 55.8 Billion | 13.88 Billion |
| Accounts receivables | -1.98 Billion | -1.07 Billion | 5.32 Billion | -506.18 Million | -1.55 Billion | -7.41 Billion |
| Accounts payables | 3.71 Billion | 1.11 Billion | 11.52 Billion | 4.23 Billion | -9.32 Billion | -5.21 Billion |
| Inventory | -8.6 Billion | -1.56 Billion | 5.81 Billion | 13.85 Billion | 19.18 Billion | -2.67 Billion |
| Other working capital | 7.07 Billion | -8.6 Billion | -7.36 Billion | -29.06 Billion | -21.71 Billion | 10.91 Billion |
| Cash at beginning of period | 48.18 Billion | 53.25 Billion | 32.56 Billion | 52.14 Billion | 38.56 Billion | 45.72 Billion |
| Cash at end of period | 48.31 Billion | 48.18 Billion | 53.25 Billion | 53.25 Billion | 32.56 Billion | 38.56 Billion |
| Capital Expenditure | -2.56 Billion | -3.28 Billion | -2.88 Billion | -18.18 Billion | -6.81 Billion | -4.62 Billion |
| Effect of forex changes on cash | 30.49 Million | 49.04 Million | -67.3 Million | -64.18 Million | 16.15 Million | -49.71 Million |
| Net cash flow / Change in cash | 133.69 Million | -5.07 Billion | 20.68 Billion | 1.11 Billion | -5.99 Billion | -7.16 Billion |
| Free Cash Flow | 4.42 Billion | -6.92 Billion | 14.51 Billion | -54.8 Billion | -33.28 Billion | -18.8 Billion |
GMTD
601100
FUR
600219
688366
BETS-B